The Board of Directors of Zoetis Inc. (NYSE:ZTS), formerly
the animal health business of Pfizer Inc., has declared a fourth-quarter
dividend payable to holders of the company’s common stock of $0.065 per
share. The dividend is to be paid on Dec. 2, 2013, to holders of record
on Nov. 1, 2013.
About Zoetis
Zoetis
(zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
complemented by diagnostic products and genetic tests and supported by a
range of services. In 2012, the company generated annual revenues of
$4.3 billion. With approximately 9,300 employees worldwide at the
beginning of 2013, Zoetis has a local presence in approximately 70
countries, including 29 manufacturing facilities in 11 countries. Its
products serve veterinarians, livestock producers and people who raise
and care for farm and companion animals in 120 countries. For more
information on the company, visit www.zoetis.com.
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
Zoetis's current views with respect to business plans or prospects,
future operating or financial performance, and other future events.
These statements are not guarantees of future performance.
Forward-looking statements are subject to risks and uncertainties. If
one or more of these risks or uncertainties materialize, or if
management's underlying assumptions prove to be incorrect, actual
results may differ materially from those contemplated by a
forward-looking statement. Forward-looking statements speak only as of
the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A
further list and description of risks, uncertainties and other matters
can be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2012, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future Results”
and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and
in our Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov,
www.zoetis.com,
or on request from Zoetis.
Media:
Bill Price, 1-973-443-2742 (o)
william.price@zoetis.com
or
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investor:
Dina Fede, 1-973-443-2969 (o)
or
John O’Connor, 1-973-822-7088 (o)